DiaMedica Therapeutics Inc.
DMAC
$5.86
-$0.17-2.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.18% | 27.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.68% | -3.27% | |||
| Operating Income | 1.68% | 3.27% | |||
| Income Before Tax | 0.10% | 2.41% | |||
| Income Tax Expenses | 0.00% | -33.33% | |||
| Earnings from Continuing Operations | 0.10% | 2.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.10% | 2.44% | |||
| EBIT | 1.68% | 3.27% | |||
| EBITDA | 1.59% | 3.27% | |||
| EPS Basic | 0.39% | 2.55% | |||
| Normalized Basic EPS | 0.36% | 2.52% | |||
| EPS Diluted | 0.39% | 2.55% | |||
| Normalized Diluted EPS | 0.36% | 2.52% | |||
| Average Basic Shares Outstanding | 0.27% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||